Obesity
Showing NaN - NaN of 171
Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)
Not yet recruiting
- Chronic Kidney Disease
- +2 more
- Cagrilintide
- +2 more
-
Concord, California
- +73 more
Nov 9, 2023
Acute Lymphoblastic Leukemia, Obesity Trial in New York (PEDALL, Standard of care)
Recruiting
- Acute Lymphoblastic Leukemia
- Obesity
- PEDALL
- Standard of care
-
New York, New YorkColumbia University Medical Center
Jul 19, 2023
Obesity Trial in New York (Naltrexone-Bupropion Combination)
Recruiting
- Obesity
- Naltrexone-Bupropion Combination
-
New York, New YorkColumbia University Medical Center
Jun 16, 2023
Cardiometabolic Syndrome, Obesity Trial in New York (Intermittent Short Sleep (ISS), Social Jetlag (SJL), Sustained Adequate
Recruiting
- Cardiometabolic Syndrome
- Obesity
- Intermittent Short Sleep (ISS)
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
May 31, 2023
Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Obesity
- Cardiovascular Diseases
- Retatrutide
- Placebo
-
Phoenix, Arizona
- +165 more
May 22, 2023
Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)
Recruiting
- Obesity
- Overweight
- Tirzepatide
- Semaglutide 2.4 mg
-
Birmingham, Alabama
- +31 more
Apr 26, 2023
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Overweight, Overweight and Obesity, Overweight or Obesity Trial in New York (Counseling, Text Messages, Phone calls)
Recruiting
- Overweight
- +4 more
- Counseling
- +3 more
-
New York, New YorkMexican Consulate's Ventanilla de Salud (VDS)
Mar 20, 2023
Obesity Trial in New York, Philadelphia (Weight loss)
Not yet recruiting
- Obesity
- Weight loss
-
New York, New York
- +3 more
Feb 17, 2023
Obesity Trial in New York (Time Restricted Eating (TRE))
Not yet recruiting
- Obesity
- Time Restricted Eating (TRE)
-
New York, New YorkNYU Langone Health
Feb 15, 2023
Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)
Recruiting
- Insulin Resistance
- +4 more
- Insulin human
- +8 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 2, 2023
Obesity, Obese, Overweight or Obesity Trial in New Zealand (biological, drug, other)
Recruiting
- Obesity
- +2 more
- Bimagrumab
- +2 more
-
Anniston, Alabama
- +23 more
Feb 1, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Obesity Trial in New York (Exendin 9-39 and Sitagliptin, Placebo)
Withdrawn
- Obesity
- Exendin 9-39 and Sitagliptin
- Placebo
-
New York, New YorkMount Sinai - Morningside
Nov 14, 2022
Preoperative Proteinuria Predict Postoperative Acute Kidney
Recruiting
- Acute Kidney Injury
- +2 more
- Urine Sample
-
New York, New YorkNYU Langone Medical Center
Oct 31, 2022
Investigate Genetic Causes of Severe Early Childhood Onset
Recruiting
- Obesity
-
New York, New York
- +1 more
Oct 28, 2022
Insulin Resistance, Obesity Trial in New York (Roux-en-Y Gastric Bypass (RYGBP), Sleeve Gastrectomy (SG), Very Low Calorie Diet
Recruiting
- Insulin Resistance
- Obesity
- Roux-en-Y Gastric Bypass (RYGBP)
- +2 more
-
New York, New YorkColumbia University Medical Center
Oct 17, 2022
Obesity, Weight Loss, Overweight and Obesity Trial in New York (Noom Healthy Weight; mobile behavior change program for weight
Completed
- Obesity
- +6 more
- Noom Healthy Weight; mobile behavior change program for weight loss.
-
New York, New YorkNoom, Inc.
Oct 5, 2022
Obesity, Overweight and Obesity, Quality of Life Trial in New York (Noom Healthy Weight)
Active, not recruiting
- Obesity
- +3 more
- Noom Healthy Weight
-
New York, New YorkNoom
Oct 5, 2022
Asthma, Obesity Trial in United States (Roflumilast 500 Mcg Oral Tablet, Placebo oral capsule)
Completed
- Asthma
- Obesity
- Roflumilast 500 Mcg Oral Tablet
- Placebo oral capsule
-
Birmingham, Alabama
- +6 more
Sep 9, 2022